212 related articles for article (PubMed ID: 22672269)
1. Heparin affin regulatory peptide modulates the endogenous anticoagulant activity of heparin and heparan sulphate mimetics.
Mejdoubi-Charef N; Courty J; Sineriz F; Papy-Garcia D; Charef S
Basic Clin Pharmacol Toxicol; 2012 Nov; 111(5):296-302. PubMed ID: 22672269
[TBL] [Abstract][Full Text] [Related]
2. Identification of heparin affin regulatory peptide domains with potential role on angiogenesis.
Polykratis A; Delbé J; Courty J; Papadimitriou E; Katsoris P
Int J Biochem Cell Biol; 2004 Oct; 36(10):1954-66. PubMed ID: 15203110
[TBL] [Abstract][Full Text] [Related]
3. Effects on coagulation of a synthetic heparan mimetic given intraperitoneally or orally.
Charef S; Petit E; Barritault D; Courty J; Caruelle JP
J Biomed Mater Res A; 2007 Dec; 83(4):1024-1031. PubMed ID: 17584894
[TBL] [Abstract][Full Text] [Related]
4. Effect of heparin on bovine epithelial lens cell proliferation induced by heparin affin regulatory peptide.
Delbé J; Vacherot F; Laaroubi K; Barritault D; Courty J
J Cell Physiol; 1995 Jul; 164(1):47-54. PubMed ID: 7790396
[TBL] [Abstract][Full Text] [Related]
5. Heparin affin regulatory peptide binds to vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis.
Héroult M; Bernard-Pierrot I; Delbé J; Hamma-Kourbali Y; Katsoris P; Barritault D; Papadimitriou E; Plouet J; Courty J
Oncogene; 2004 Mar; 23(9):1745-53. PubMed ID: 15001987
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms for the anticoagulant effect of heparin and related polysaccharides.
Ofosu FA
Nouv Rev Fr Hematol (1978); 1988; 30(3):155-60. PubMed ID: 2971155
[TBL] [Abstract][Full Text] [Related]
7. Glycosaminoglycans promote HARP/PTN dimerization.
Bernard-Pierrot I; Héroult M; Lemaître G; Barritault D; Courty J; Milhiet PE
Biochem Biophys Res Commun; 1999 Dec; 266(2):437-42. PubMed ID: 10600521
[TBL] [Abstract][Full Text] [Related]
8. Glycosaminoglycans differentially bind HARP and modulate its biological activity.
Vacherot F; Delbé J; Heroult M; Barritault D; Fernig DG; Courty J
J Biol Chem; 1999 Mar; 274(12):7741-7. PubMed ID: 10075664
[TBL] [Abstract][Full Text] [Related]
9. A non-hemorrhagic hybrid heparin/heparan sulfate with anticoagulant potential.
Brito AS; Cavalcante RS; Palhares LC; Hughes AJ; Andrade GP; Yates EA; Nader HB; Lima MA; Chavante SF
Carbohydr Polym; 2014 Jan; 99():372-8. PubMed ID: 24274520
[TBL] [Abstract][Full Text] [Related]
10. Heparanase modulates heparinoids anticoagulant activities via non-enzymatic mechanisms.
Katz BZ; Muhl L; Zwang E; Ilan N; Herishanu Y; Deutsch V; Naparstek E; Vlodavsky I; Preissner KT
Thromb Haemost; 2007 Dec; 98(6):1193-9. PubMed ID: 18064313
[TBL] [Abstract][Full Text] [Related]
11. Neutralization of the anticoagulant effects of glycosaminoglycans by serum amyloid P component: comparison with other plasma and platelet proteins.
Williams EC; Huppert BJ; Asakura S
J Lab Clin Med; 1992 Jul; 120(1):159-67. PubMed ID: 1377216
[TBL] [Abstract][Full Text] [Related]
12. Neutralisation of heparan sulphate and low molecular weight heparin by protamine.
Hubbard AR; Jennings CA
Thromb Haemost; 1985 Feb; 53(1):86-9. PubMed ID: 3158095
[TBL] [Abstract][Full Text] [Related]
13. Effect of a heparan sulphate with high affinity for antithrombin III upon inactivation of thrombin and coagulation factor Xa.
Scully MF; Ellis V; Shah N; Kakkar V
Biochem J; 1989 Sep; 262(2):651-8. PubMed ID: 2529852
[TBL] [Abstract][Full Text] [Related]
14. Comparative effect of heparin and heparan sulphate on two abnormal antithrombin III type 3 variants.
Fischer AM; Beguin S; Sternberg C; Dautzenberg MD
Br J Haematol; 1987 Jun; 66(2):213-7. PubMed ID: 2955807
[TBL] [Abstract][Full Text] [Related]
15. Glycosaminoglycan Neutralization in Coagulation Control.
Sobczak AIS; Pitt SJ; Stewart AJ
Arterioscler Thromb Vasc Biol; 2018 Jun; 38(6):1258-1270. PubMed ID: 29674476
[TBL] [Abstract][Full Text] [Related]
16. Increased sulphation improves the anticoagulant activities of heparan sulphate and dermatan sulphate.
Ofosu FA; Modi GJ; Blajchman MA; Buchanan MR; Johnson EA
Biochem J; 1987 Dec; 248(3):889-96. PubMed ID: 2963622
[TBL] [Abstract][Full Text] [Related]
17. Heparin chain-length dependence of factor Xa inhibition by antithrombin in plasma.
Rezaie AR
Thromb Res; 2007; 119(4):481-8. PubMed ID: 16515805
[TBL] [Abstract][Full Text] [Related]
18. Effects on platelets and on the clotting system of four glycosaminoglycans extracted from hog mucosa and one extracted from aortic intima of the calf.
Cella G; Scattolo N; Luzzatto G; Stevanato F; Vio C; Girolami A
J Med; 1986; 17(5-6):331-46. PubMed ID: 2953835
[TBL] [Abstract][Full Text] [Related]
19. The angiogenic factor heparin affin regulatory peptide (HARP) induces proliferation of human peripheral blood mononuclear cells.
Achour A; Laaroubi D; Caruelle D; Barritault D; Courty J
Cell Mol Biol (Noisy-le-grand); 2001; 47 Online Pub():OL73-7. PubMed ID: 11936877
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of B16-BL6 melanoma lung colonies by semisynthetic sulfaminoheparosan sulfates from E. coli K5 polysaccharide.
Poggi A; Rossi C; Casella N; Bruno C; Sturiale L; Dossi C; Naggi A
Semin Thromb Hemost; 2002 Aug; 28(4):383-92. PubMed ID: 12244486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
